Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis

Objectives: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). Methods...

Full description

Bibliographic Details
Main Authors: Riley J. Batchelor, Andrew Wheelahan, Wayne C. Zheng, Dion Stub, Yang Yang, William Chan
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/14/3955
_version_ 1797433486623113216
author Riley J. Batchelor
Andrew Wheelahan
Wayne C. Zheng
Dion Stub
Yang Yang
William Chan
author_facet Riley J. Batchelor
Andrew Wheelahan
Wayne C. Zheng
Dion Stub
Yang Yang
William Chan
author_sort Riley J. Batchelor
collection DOAJ
description Objectives: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). Methods: Electronic databases of MEDLINE, EMBASE and CENTRAL were systematically searched in November 2021. Studies directly comparing the use of Impella (CP, 2.5 or 5.0) with VA-ECMO for AMI-CS were included. Studies examining other modalities of MCS, or other causes of cardiogenic shock, were excluded. The primary outcome was in-hospital mortality. Results: No randomised trials comparing VA-ECMO to Impella in patients with AMI-CS were identified. Six cohort studies (five retrospective and one prospective) were included for systematic review. All studies, including 7093 patients, were included in meta-analysis. Five studies reported in-hospital mortality, which, when pooled, was 42.4% in the Impella group versus 50.1% in the VA-ECMO group. Impella support for AMI-CS was associated with an 11% relative risk reduction in in-hospital mortality compared to VA-ECMO (risk ratio 0.89; 95% CI 0.83–0.96, I<sup>2</sup> 0%). Of the six studies, three studies also adjusted outcome measures via propensity-score matching with reported reductions in in-hospital mortality with Impella compared to VA-ECMO (risk ratio 0.72; 95% CI 0.59–0.86, I<sup>2</sup> 35%). Pooled analysis of five studies with 6- or 12-month mortality data reported a 14% risk reduction with Impella over the medium-to-long-term (risk ratio 0.86; 95% CI 0.76–0.97, I<sup>2</sup> 0%). Conclusions: There is no high-level evidence comparing VA-ECMO and Impella in AMI-CS. In available observation studies, MCS with Impella was associated with a reduced risk of in-hospital and medium-term mortality as compared to VA-ECMO.
first_indexed 2024-03-09T10:17:41Z
format Article
id doaj.art-c000dc978d644ab9af704feb079f66e1
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T10:17:41Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-c000dc978d644ab9af704feb079f66e12023-12-01T22:17:46ZengMDPI AGJournal of Clinical Medicine2077-03832022-07-011114395510.3390/jcm11143955Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-AnalysisRiley J. Batchelor0Andrew Wheelahan1Wayne C. Zheng2Dion Stub3Yang Yang4William Chan5Department of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaDepartment of Cardiology, Western Health, Melbourne 3004, AustraliaDepartment of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaDepartment of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaIntensive Care Unit, Western Health, Melbourne 3004, AustraliaDepartment of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaObjectives: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). Methods: Electronic databases of MEDLINE, EMBASE and CENTRAL were systematically searched in November 2021. Studies directly comparing the use of Impella (CP, 2.5 or 5.0) with VA-ECMO for AMI-CS were included. Studies examining other modalities of MCS, or other causes of cardiogenic shock, were excluded. The primary outcome was in-hospital mortality. Results: No randomised trials comparing VA-ECMO to Impella in patients with AMI-CS were identified. Six cohort studies (five retrospective and one prospective) were included for systematic review. All studies, including 7093 patients, were included in meta-analysis. Five studies reported in-hospital mortality, which, when pooled, was 42.4% in the Impella group versus 50.1% in the VA-ECMO group. Impella support for AMI-CS was associated with an 11% relative risk reduction in in-hospital mortality compared to VA-ECMO (risk ratio 0.89; 95% CI 0.83–0.96, I<sup>2</sup> 0%). Of the six studies, three studies also adjusted outcome measures via propensity-score matching with reported reductions in in-hospital mortality with Impella compared to VA-ECMO (risk ratio 0.72; 95% CI 0.59–0.86, I<sup>2</sup> 35%). Pooled analysis of five studies with 6- or 12-month mortality data reported a 14% risk reduction with Impella over the medium-to-long-term (risk ratio 0.86; 95% CI 0.76–0.97, I<sup>2</sup> 0%). Conclusions: There is no high-level evidence comparing VA-ECMO and Impella in AMI-CS. In available observation studies, MCS with Impella was associated with a reduced risk of in-hospital and medium-term mortality as compared to VA-ECMO.https://www.mdpi.com/2077-0383/11/14/3955acute myocardial infarctioncardiogenic shockVA-ECMOImpellamechanical circulatory support
spellingShingle Riley J. Batchelor
Andrew Wheelahan
Wayne C. Zheng
Dion Stub
Yang Yang
William Chan
Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine
acute myocardial infarction
cardiogenic shock
VA-ECMO
Impella
mechanical circulatory support
title Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
title_full Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
title_fullStr Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
title_full_unstemmed Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
title_short Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
title_sort impella versus venoarterial extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock a systematic review and meta analysis
topic acute myocardial infarction
cardiogenic shock
VA-ECMO
Impella
mechanical circulatory support
url https://www.mdpi.com/2077-0383/11/14/3955
work_keys_str_mv AT rileyjbatchelor impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis
AT andrewwheelahan impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis
AT wayneczheng impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis
AT dionstub impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis
AT yangyang impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis
AT williamchan impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis